Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer’s disease
Abstract Clinical trial participation across disease areas, including Alzheimer’s disease (AD), has been biased towards White participants of European ancestry.…